BDX
BECTON DICKINSON & CO
$146.24
-0.75%
$40.3B
No data for this timeframe.
Vol
Market Cap$40.3B
Cap SizeLarge Cap
Analyst ConsensusHold (43%)
Inst. Holders50 funds
Inst. Value$27.6B
Inst. Activity20 buys / 30 sells
Insider Activity0B / 6S
Insider Net $-$618.8K
Reddit Sentiment43° Neutral
SEC Reports4
Congressional1 trades
Exchange NYSE·Sector Surgical & Medical Instruments & Apparatus·Inc. NJ·CIK 0000010795·Prev Close $147.35
Recent Activity
Jun 10, 2026
Insider
Garrison Michael David sold 1,100 shares
EVP & Pres Med.Essntl&BioPharm @ $151.48 ($166.6K)
Jun 10, 2026
short_volume
Short Volume: BDX — 65.6% short (0.5M / 0.8M)
Short: 516,594 | Exempt: 2,704 | TRF Vol: 787,348 | Short Ratio: 65.6% | Off-exchange volume (dark p
Jun 3, 2026
SEC
CEO Thomas Polen executed a multi-leg transaction on June 1: exercised 20,209 options at $126.16, surrendered 17,445 sha
CLUSTER — Impact 2/10
Jun 1, 2026
Insider
Menziuso Peter was granted 14,258 shares
EVP and President, BDI
Jun 1, 2026
Insider
Polen Thomas E Jr acquired via exercise 20,209 shares
Chairman, CEO and President @ $126.16 ($2.5M)
May 29, 2026
SEC
BDX disclosed it has resumed shipment of ChloraPrep in the U.S. after voluntarily placing the product on hold on May 6,
8-K — Impact 4/10
Apr 21, 2026
SEC
BD reported Q1 FY26 adjusted EPS of $2.91, missing consensus by 4.5% and revenue of $4.49B, beating by 2.8%, while reaff
8-K — Impact 6/10
Inst.
Invesco Ltd. — DOUBLED
10,174,327 shares ($1.6B)
Price Targets
$180.69
+23.6% upside
Strong Buy
Current $146.24
Low $150.00
Median $175.00
High $225.00
13 analysts
$150.00
$225.00
Analyst Ratings
5Strong Buy
4Buy
12Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 11, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
| May 8, 2026 | Wells Fargo | MAINTAIN | Equal-Weight → Equal-Weight |
| May 4, 2026 | TD Cowen | MAINTAIN | Hold → Hold |
| Apr 17, 2026 | Piper Sandler | MAINTAIN | Neutral → Neutral |
| Mar 23, 2026 | Argus Research | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $3.13 | $3.06 — $3.19 | -15% YoY | 11 |
| Next Q | $4.08 | $3.89 — $4.16 | 3% YoY | 11 |
| Current FY | $12.54 | $12.00 — $12.65 | -13% YoY | 14 |
| Next FY | $13.39 | $13.04 — $13.70 | 7% YoY | 14 |
Latest Reports
NEUTRAL
CLUSTER
2/10
CEO Thomas Polen executed a multi-leg transaction on June 1: exercised 20,209 options at $126.16, surrendered 17,445 sha
Jun 3, 2026
NEUTRAL
8-K
4/10
BDX disclosed it has resumed shipment of ChloraPrep in the U.S. after voluntarily placing the product on hold on May 6,
May 29, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $4.1B | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.9B | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.4B | — |
| MASSACHUSETTS FINANCIAL SERVICES CO | $2.2B | — |
| STATE STREET CORP | $2.2B | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 10, 2026 | Garrison Michael | SELL | $166.6K |
| Jun 1, 2026 | Menziuso Peter | A | $0.00 |
| Jun 1, 2026 | Polen Thomas | M | $2.5M |
| Jun 1, 2026 | Polen Thomas | SELL | $404.5K |
| Jun 1, 2026 | Polen Thomas | D | $2.5M |
Reddit Sentiment
43°
Neutral
Bearish
Neutral
Bullish
Congressional Trades
1 members: 0 buys, 1 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| Kevin Hern | R | SELL | $15,001 - $50,000 |
50 institutional holders with $27.6B total value (170,594,813 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, VANGUARD. Net selling activity: 30 institutions trimmed/exited vs 20 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 26,153,411 | $4.1B | 14.9% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 18,490,610 | $2.9B | 10.5% | — |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 15,317,242 | $2.4B | 8.7% | — |
| 4 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 9,101,454 | $2.2B | 8.0% | — |
| 5 | STATE STREET CORP | 13,822,808 | $2.2B | 7.9% | — |
| 6 | First Eagle Investment Management, LLC | 11,928,111 | $1.9B | 6.8% | — |
| 7 | Invesco Ltd. | 10,174,327 | $1.6B | 5.8% | DOUBLED +168.4% |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 6,615,230 | $1.0B | 3.8% | — |
| 9 | FRANKLIN RESOURCES INC | 5,362,965 | $843.2M | 3.1% | — |
| 10 | Clearbridge Investments, LLC | 4,140,042 | $650.9M | 2.4% | — |
| 11 | MORGAN STANLEY | 4,020,672 | $632.2M | 2.3% | — |
| 12 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3,324,127 | $523.0M | 1.9% | — |
| 13 | BANK OF AMERICA CORP /DE/ | 2,668,446 | $419.6M | 1.5% | — |
| 14 | GOLDMAN SACHS GROUP INC | 2,482,108 | $390.3M | 1.4% | — |
| 15 | NORDEA INVESTMENT MANAGEMENT AB | 2,435,206 | $376.1M | 1.4% | — |
| 16 | DIMENSIONAL FUND ADVISORS LP | 2,271,757 | $357.1M | 1.3% | — |
| 17 | HARRIS ASSOCIATES L P | 2,222,039 | $349.4M | 1.3% | — |
| 18 | Legal & General Group Plc | 2,070,929 | $325.6M | 1.2% | — |
| 19 | Amundi | 1,630,162 | $256.3M | 0.9% | — |
| 20 | VANGUARD FIDUCIARY TRUST CO | 1,603,444 | $252.1M | 0.9% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| Invesco Ltd. | DOUBLED | 3,790,490 | 10,174,327 | +168.4% | $1.6B | 2026-Q1 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | TRIM | 2,384,372 | 1,371,180 | -42.5% | $215.6M | 2026-Q1 |
| FMR LLC | TRIM | 1,532,988 | 1,086,716 | -29.1% | $170.9M | 2026-Q1 |
| HSBC HOLDINGS PLC | TRIM | 940,908 | 682,358 | -27.5% | $107.1M | 2026-Q1 |
| Starboard Value LP | TRIM | 929,917 | 636,494 | -31.6% | $100.1M | 2026-Q1 |
| 1832 Asset Management L.P. | TRIM | 1,366,829 | 611,764 | -55.2% | $96.2M | 2026-Q1 |
| BANK OF MONTREAL /CAN/ | TRIM | 536,242 | 398,623 | -25.7% | $62.7M | 2026-Q1 |
| ASSETMARK, INC | ADD | 270,910 | 355,449 | +31.2% | $55.9M | 2026-Q1 |
| Mawer Investment Management Ltd. | TRIM | 543,136 | 355,221 | -34.6% | $55.9M | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | NEAR_EXIT | 1,388,854 | 271,657 | -80.4% | $42.7M | 2026-Q1 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | NEW | — | 241,115 | — | $37.9M | 2026-Q1 |
| EXCHANGE TRADED CONCEPTS, LLC | ADD | 129,286 | 237,971 | +84.1% | $37.4M | 2026-Q1 |
| Rockefeller Capital Management L.P. | NEAR_EXIT | 1,657,503 | 224,259 | -86.5% | $35.3M | 2026-Q1 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | DOUBLED | 79,626 | 181,812 | +128.3% | $28.6M | 2026-Q1 |
| BNP Paribas Asset Management Holding S.A. | TRIM | 249,585 | 146,334 | -41.4% | $23.0M | 2026-Q1 |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | NEAR_EXIT | 730,570 | 142,180 | -80.5% | $22.4M | 2026-Q1 |
| FIFTH THIRD BANCORP | DOUBLED | 27,550 | 118,779 | +331.1% | $18.7M | 2026-Q1 |
| TORONTO DOMINION BANK | TRIM | 174,210 | 94,078 | -46.0% | $14.8M | 2026-Q1 |
| DIAMOND HILL CAPITAL MANAGEMENT INC | TRIM | 152,941 | 93,361 | -39.0% | $14.7M | 2026-Q1 |
| TD Waterhouse Canada Inc. | DOUBLED | 20,839 | 82,134 | +294.1% | $13.9M | 2026-Q1 |
| Tredje AP-fonden | TRIM | 291,720 | 86,589 | -70.3% | $13.6M | 2026-Q1 |
| CREDIT AGRICOLE S A | TRIM | 178,581 | 84,490 | -52.7% | $13.3M | 2026-Q1 |
| NATIONAL BANK OF CANADA /FI/ | TRIM | 195,751 | 78,384 | -60.0% | $12.3M | 2026-Q1 |
| Holocene Advisors, LP | NEAR_EXIT | 1,165,774 | 76,973 | -93.4% | $12.1M | 2026-Q1 |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | ADD | 51,971 | 65,371 | +25.8% | $10.3M | 2026-Q1 |
11 unique insiders with 19 transactions. Net insider value: -$618.8K ($0.00 bought, $618.8K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | SELL | 1,100 | $151.48 | $166.6K |
| Jun 1, 2026 | Menziuso Peter | EVP and President, BDI | AWARD | 14,258 | — | — |
| Jun 1, 2026 | Polen Thomas E Jr | Chairman, CEO and President | EXERCISE | 20,209 | $126.16 | $2.5M |
| Jun 1, 2026 | Polen Thomas E Jr | Chairman, CEO and President | SELL | 2,764 | $146.35 | $404.5K |
| Jun 1, 2026 | Polen Thomas E Jr | Chairman, CEO and President | D | 17,445 | $146.15 | $2.5M |
| May 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | SELL | 75 | $147.35 | $11.1K |
| May 8, 2026 | Byington Carrie L | Director | AWARD | 105 | $149.04 | $15.6K |
| May 8, 2026 | Huffines Robert Luther | Director | AWARD | 210 | $149.04 | $31.3K |
| May 7, 2026 | Roque Vitor | EVP & Chief Financial Officer | AWARD | 1,721 | — | — |
| Apr 27, 2026 | Feld Michael | EVP, Chief Revenue Officer | SELL | 74 | $151.94 | $11.2K |
| Apr 6, 2026 | Neal Shana Carol | EVP and Chief People Officer | TAX W/H | 1,146 | — | — |
| Mar 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | SELL | 75 | $156.83 | $11.8K |
| Mar 16, 2026 | Minnix Lanesha | EVP and General Counsel | AWARD | 7,492 | — | — |
| Mar 2, 2026 | Roque Vitor | Interim CFO | AWARD | 931 | — | — |
| Mar 2, 2026 | Spikner Pamela L. | SVP Controller & CAO | AWARD | 931 | — | — |
| Feb 26, 2026 | Feld Michael | EVP, Chief Revenue Officer | SELL | 75 | $181.84 | $13.6K |
| Feb 4, 2026 | Byington Carrie L | Director | AWARD | 30 | $201.91 | $6.1K |
| Feb 4, 2026 | Jones Christopher Ian Montague | Director | AWARD | 272 | $201.91 | $54.9K |
| Feb 4, 2026 | Huffines Robert Luther | Director | AWARD | 100 | $201.91 | $20.2K |
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 3 neutral. Avg impact: 4.3/10.
NEUTRAL
CLUSTER
2/10
CEO Thomas Polen executed a multi-leg transaction on June 1: exercised 20,209 options at $126.16, su
Jun 3, 2026
NEUTRAL
8-K
4/10
BDX disclosed it has resumed shipment of ChloraPrep in the U.S. after voluntarily placing the produc
May 29, 2026
MIXED
8-K
6/10
BD reported Q1 FY26 adjusted EPS of $2.91, missing consensus by 4.5% and revenue of $4.49B, beating
Apr 21, 2026
NEUTRAL
8-K
5/10
Becton, Dickinson and Company (BDX) announced the pricing and acceptance results of its tender offer
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Hold (43% buy). Based on 21 analysts: 5 strong buy, 4 buy, 12 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$180.69 mean target
+23.6% upside
Strong Buy (2.20)
$150.00 Low
$225.00 High
| Metric | Value |
|---|---|
| Current Price | $146.24 |
| Target Low | $150.00 |
| Target Mean | $180.69 |
| Target Median | $175.00 |
| Target High | $225.00 |
| # Analysts | 13 |
| Recommendation | Strong Buy (2.20) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$3.13 | $3.06 | $3.19 | -14.9% | +0.1% | 9↑ 2↓ | $4.9B | -11.3% | 11 |
| Next Q 2026-09-30 |
$4.08 | $3.89 | $4.16 | 2.9% | -0.5% | 1↑ 10↓ | $5.1B | -13.0% | 11 |
| Current FY 2026-09-30 |
$12.54 | $12.00 | $12.65 | -12.9% | -0.1% | 10↑ 1↓ | $19.2B | -12.1% | 14 |
| Next FY 2027-09-30 |
$13.39 | $13.04 | $13.70 | 6.8% | -0.4% | 7↑ 5↓ | $19.7B | 2.6% | 14 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $3.131 | |
| 7d ago | $3.131 | |
| 30d ago | $3.129 | +0.002 |
| 60d ago | $3.087 | +0.043 |
| 90d ago | $3.071 | +0.059 |
11 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 11, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| May 8, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| May 4, 2026 | TD Cowen | MAINTAIN | Hold | Hold |
| Apr 17, 2026 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| Mar 23, 2026 | Argus Research | MAINTAIN | Buy | Buy |
| Feb 11, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Feb 10, 2026 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Feb 10, 2026 | Jefferies | MAINTAIN | Buy | Buy |
| Feb 10, 2026 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
| Feb 10, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Feb 10, 2026 | Piper Sandler | REITERATE | Neutral | Neutral |
| Feb 10, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | Equal-Weight |
| Jan 28, 2026 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| Jan 7, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Jan 5, 2026 | B of A Securities | MAINTAIN | Neutral | Neutral |
| Dec 17, 2025 | RBC Capital | MAINTAIN | Sector Perform | Sector Perform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 4 | 12 | 0 | 0 | 43% | |
| May 1, 2026 | 5 | 5 | 11 | 0 | 0 | 48% | |
| Apr 1, 2026 | 5 | 4 | 11 | 0 | 0 | 45% | |
| Mar 1, 2026 | 5 | 4 | 11 | 0 | 0 | 45% | |
| Feb 1, 2026 | 4 | 3 | 11 | 0 | 0 | 39% | |
| Jan 1, 2026 | 4 | 3 | 11 | 0 | 0 | 39% |
Strong BuyBuyHoldSellStrong Sell
1 members of Congress traded this stock: 0 buys, 1 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Kevin Hern | R | HOUSE | SELL | $15,001 - $50,000 | Becton Dickinson and Co | Apr 6, 2026 (21d) |
43°
Neutral
Bearish
Neutral
Bullish
3 mentions
0 bullish
1 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 25, 2026 | 2 | 42° Neutral | 0 | 1 | 2 |
| May 25, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
Jun 10, 2026
short_volume
Short Volume: BDX — 65.6% short (0.5M / 0.8M)
Short: 516,594 | Exempt: 2,704 | TRF Vol: 787,348 | Short Ratio: 65.6% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: BDX — 60.9% short (0.5M / 0.8M)
Short: 505,650 | Exempt: 70 | TRF Vol: 830,689 | Short Ratio: 60.9% | Off-exchange volume (dark pool + OTC)
Jun 4, 2026
short_volume
Short Volume: BDX — 66.0% short (0.5M / 0.7M)
Short: 481,479 | Exempt: 398 | TRF Vol: 729,490 | Short Ratio: 66.0% | Off-exchange volume (dark pool + OTC)
Jun 3, 2026
short_volume
Short Volume: BDX — 67.4% short (0.5M / 0.7M)
Short: 453,864 | Exempt: 122 | TRF Vol: 673,625 | Short Ratio: 67.4% | Off-exchange volume (dark pool + OTC)
Jun 2, 2026
short_volume
Short Volume: BDX — 60.7% short (0.8M / 1.3M)
Short: 767,827 | Exempt: 279 | TRF Vol: 1,265,403 | Short Ratio: 60.7% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: BDX — 62.6% short (0.7M / 1.1M)
Short: 658,104 | Exempt: 2,232 | TRF Vol: 1,051,402 | Short Ratio: 62.6% | Off-exchange volume (dark pool + OTC)
May 26, 2026
short_volume
Short Volume: BDX — 55.7% short (0.7M / 1.3M)
Short: 705,569 | Exempt: 1,980 | TRF Vol: 1,265,689 | Short Ratio: 55.7% | Off-exchange volume (dark pool + OTC)
May 25, 2026
dark_pool
Dark Pool: BDX — 3.5M shares, 71,306 trades
Week starting 2026-05-25. Total ATS volume: 3,544,098 shares across 71,306 trades.
May 21, 2026
short_volume
Short Volume: BDX — 57.5% short (0.5M / 0.8M)
Short: 468,575 | Exempt: 2,439 | TRF Vol: 815,090 | Short Ratio: 57.5% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: BDX — 61.2% short (0.7M / 1.1M)
Short: 679,926 | Exempt: 74 | TRF Vol: 1,111,640 | Short Ratio: 61.2% | Off-exchange volume (dark pool + OTC)
May 18, 2026
dark_pool
Dark Pool: BDX — 4.3M shares, 81,627 trades
Week starting 2026-05-18. Total ATS volume: 4,293,213 shares across 81,627 trades.
May 11, 2026
dark_pool
Dark Pool: BDX — 5.7M shares, 91,334 trades
Week starting 2026-05-11. Total ATS volume: 5,700,775 shares across 91,334 trades.
May 8, 2026
short_interest
FTD: BDX — 299,911 shares ($46.0M) failed to deliver
Settlement: 20260508, Price: $153.26, FTD Value: $45,964,359.86, BECTON DICKINSON & CO
May 7, 2026
earnings_calendar
BDX Q2 2026 Earnings Scheduled — 2026-05-07
May 7, 2026
short_volume
Short Volume: BDX — 57.5% short (1.5M / 2.7M)
Short: 1,532,686 | Exempt: 91,148 | TRF Vol: 2,664,598 | Short Ratio: 57.5% | Off-exchange volume (dark pool + OTC)
Feb 24, 2026
Clinical Trial
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
Phase Phase 2 — COMPLETED